Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Use of Integrated Molecular Testing in the Assessment and Management of Pancreatic Cysts.

Current gastroenterology reports - 1 Aug 2023

Kirschenbaum Joshua D, Gonda Tamas A

Abstract excerpt

PURPOSE OF REVIEW: As abdominal imaging becomes more sensitive and regularly used, pancreatic cystic lesions (PCLs) are being diagnosed more frequently. A small but clinically significant minority of these lesions have a predisposition to either harbor malignancy or undergo malignant transformation. This review highlights the current state and performance of cystic fluid biomarkers and how they may be...

Topics

Join the communities discussing this publication.

Biomarkers
Molecular Diagnostic Techniques
Mutation
Pancreatic Neoplasms

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37407751
DOI: 10.1007/s11894-023-00877-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Use of Integrated Molecular Testing in the Assessment and Management of Pancreatic Cysts.PMID 37407751Read ↗

Biomarkers in cystic lesions of the pancreas: Controversies and advances.Semantic proximity Read ↗

Genomic alterations in pancreatic cystic neoplasms: from molecular characterization to precision clinical managementSemantic proximity Read ↗

A combination of molecular markers and clinical features improve the classification of pancreatic cysts.Semantic proximity Read ↗

An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid.Semantic proximity Read ↗

Molecular analysis of cyst fluid aspiration in the diagnosis and risk assessment of cystic lesions of the pancreas.Semantic proximity Read ↗

Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort.Semantic proximity Read ↗

Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.Semantic proximity Read ↗

A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic CystsSemantic proximity Read ↗

Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts.Semantic proximity Read ↗

Clinical utility of incorporating next-generation sequencing results in the management algorithm of pancreatic cysts.Semantic proximity Read ↗

Proteomic Mucin Profiling for the Identification of Cystic Precursors of Pancreatic CancerSemantic proximity Read ↗

Molecular diagnosis of pancreatic and biliary cancer: ready for broad implementation?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.